Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DM1P | ISIN: NL0012047823 | Ticker-Symbol: 27V
Tradegate
26.04.24
16:04 Uhr
2,520 Euro
+0,015
+0,60 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AVANTIUM NV Chart 1 Jahr
5-Tage-Chart
AVANTIUM NV 5-Tage-Chart
RealtimeGeldBriefZeit
2,4902,53513:04
2,4952,51026.04.
GlobeNewswire (Europe)
168 Leser
Artikel bewerten:
(1)

Avantium N.V.: Well Capitalised and Continued Good Progress in the Execution of its Strategy

AMSTERDAM, 20 March 2024, 22:00 hrs CET - Avantium N.V., a leading company in renewable and circular polymer materials, today reports its unaudited 2023 full year results.

Tom van Aken, Chief Executive Officer of Avantium, said: "Avantium is fast approaching the greatest inflection point in its history. Nearly two decades after it all started, we are preparing to begin commercial operations at our FDCA Flagship Plant in 2024. Throughout 2023, we achieved multiple notable milestones, including the signing of our first technology licensing agreement and securing additional offtake agreements for the FDCA Flagship Plant. The FDCA Flagship Plant construction is progressing well with the first commissioning activities recently initiated. The construction of the FDCA Flagship Plant has been impacted by rising costs, and we greatly appreciate the support of our strategic partners and lenders in securing an extra financing package. Following the successful equity raise of €70 million in February 2024, we expect to remain well-capitalised until our Flagship Plant is fully commercially operational.

In other areas of the Company, 2023 proved to be a strong year for our carbon capture and utilisation (CCU) solution Volta Technology, with the business signing collaborations with global industry leaders SCGC and Norsk Hydro. Our plants-to-glycols Ray Technology made encouraging progress from both a technical and a commercial perspective. Nonetheless, to reinforce our strategic focus on the commercialisation of FDCA and PEF, we have decided to put further investments in our Ray Technology on hold. For our R&D Solutions business, we believe our new business plan will continue to deliver growth.

Looking ahead, we are well-positioned to create sustainable long-term value for our stakeholders. We would like to thank our partners and shareholders for their ongoing trust and loyalty, and our colleagues for their commitment and determination to bring a new plant-based polymer to the market. With the successful completion of our recent fundraise, we are well positioned to start-up our FDCA Flagship Plant, launch PEF products on the market and accelerate the implementation of our FDCA/PEF licensing strategy."

Press release:
https://www.avantium.com/wp-content/uploads/2024/03/20240320-Avantium-Well-Capitalised-and-Continued-Good-Progress-in-the-Execution-of-its-Strategy.pdf
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.